Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled, "Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.